Japan· JP-2123005C1030
カルテオロール塩酸塩
A carteolol product containing カルテオロール塩酸塩, registered in Japan by 大塚製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- カルテオロール塩酸塩
- Manufacturer
- 大塚製薬
- Country
- Japan (JP)
- ATC code
- C07AA15
- ATC class
- Carteolol
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
190 interactions on record for carteolol.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carteolol · interactions on record
190 records
- 30 severe
- 144 moderate
- 16 minor
Most severe, free to view
- DolasetronA04AA04severe
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carteolol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarteolol 1% eye dropsLexon (UK) Ltd
- BelgiumArteoptic LA 1 %Bausch & Lomb Pharma
- ItalyCARTEABAK*collirio 5 ml 1%LABORATOIRES THEA
- FranceCARTEOL 1 %, collyre en solutionLABORATOIRE CHAUVIN
- SpainARTEOPTIC 1% COLIRIO DE LIBERACION PROLONGADABausch + Lomb Ireland Limited
- PolandCarteol LP 2%Medezin Sp. z o.o.
- SwitzerlandArteoptic LA
- NetherlandsArteoptic zonder conserveermiddel 20 mg/ml, oogdruppels, oplossing met verlengde afgifteBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Arteoptic La, Arteoptic La Sine Conservans
- Czechia · Carteol Lp, Carteol Neo
- Spain · Arteoptic, Arteoptic Pf
- France · Carteol, Carteol L.P.
- Croatia · Cartelomb
- Italy · Carteabak, Carteol
- Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
- Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
- Poland · Carteol Lp, Carteol Lp Preservative Free
- Portugal · Physioglau, Physioglau Pf
- Slovenia · Cartelomb
- Slovakia · Carteol Lp, Carteol Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e86f1dca-49bf-4a04-bb52-89c387a8e5f5 GET /v1/drugs/e86f1dca-49bf-4a04-bb52-89c387a8e5f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．２％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2123005C1030",
"category": "内用薬",
"price_yen": 6.9,
"generic_name": "カルテオロール塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2123",
"transitional_expiry": null
}See everything about carteolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.